Magnesium Demo (Magnesium Sulfate Heptahydrate)

Magnesium sulfate releases magnesium ions that act as cofactors for many enzymatic reactions, stabilize cell membranes, and antagonise calcium entry. This results in vasodilation, bronchodilation, and modulation of neuronal excitability, helping to prevent seizures, normalize cardiac rhythm, and improve muscle function.

The appropriate dose of Magnesium Demo is determined by the prescribing clinician based on the patient’s condition, weight, renal function and serum magnesium level. Dosage regimens vary widely, so the prescriber sets the exact infusion rate and total amount.

Magnesium sulfate is classified as a pregnancy category that should be used only when clearly indicated. It may be administered to pregnant women for eclampsia under strict medical supervision. Limited data are available for breastfeeding, and the decision should be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Magnesium Demo is an injectable magnesium sulfate formulation, offering rapid correction of severe deficiency and immediate therapeutic effect, unlike oral magnesium salts which have slower absorption. Compared with other IV magnesium products, it provides a well‑established safety profile and is widely used for obstetric and cardiac emergencies.

Magnesium Demo should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect from moisture and light. Do not freeze the product. Before use, inspect the solution for particulate matter or discoloration and discard if any abnormalities are observed.

Magnesium Demo is given by intravenous infusion. The rate and duration are set by the prescriber, often starting with a loading dose followed by a maintenance infusion, while monitoring vital signs, serum magnesium levels and cardiac rhythm throughout the procedure.

The most serious risks include severe hypotension, respiratory depression, cardiac arrest, hypermagnesemia leading to neuromuscular weakness, and rare anaphylactic reactions. Continuous monitoring of blood pressure, respiratory status and serum magnesium is essential to detect and manage these complications promptly.

Magnesium Demo is contraindicated in patients with known hypersensitivity to magnesium sulfate, severe renal failure where magnesium clearance is markedly reduced, and in those with existing hypermagnesemia. Caution is also advised for patients with heart block, myasthenia gravis or concurrent use of potent neuromuscular blockers.